Binimetinib Cyclized Impurity - Request Quote
Binimetinib Cyclized Impurity
| SZ CAT No: | SZ-B053005 |
| CAS No | NA |
| Mol.F. | C21H23BrF2N4O4 |
| Mol.Wt. | 513.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Binimetinib Cyclized Impurity is chemically 5-((4-Bromo-2-fluorophenyl)amino)-N-(2-(1-ethoxyethoxy)ethoxy)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxamide. Binimetinib Cyclized Impurity is supplied with detailed characterization data compliant with regulatory guideline. Binimetinib Cyclized Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Binimetinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Binimetinib Cyclized Impurity
Purchase Binimetinib Cyclized Impurity
Binimetinib Cyclized Impurity suppliers
Binimetinib Cyclized Impurity manufacturers
Binimetinib Cyclized Impurity price
Order Binimetinib Cyclized Impurity
Enquire Binimetinib Cyclized Impurity
Binimetinib Cyclized Impurity cost
Binimetinib Cyclized Impurity Supplier
Binimetinib Cyclized Impurity Distributor
Binimetinib Cyclized Impurity for Method Validation
Binimetinib Reference Standard
Binimetinib Cyclized Impurity for ANDA Filing
Binimetinib Cyclized Impurity for Forced Degradation Studies
Binimetinib Cyclized Impurity Identification Standards
Binimetinib Cyclized Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.